Globus Medical, Inc. (GMED)

Globus Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1,898	1,568	1,023	958.1	789.04	785.37
Revenue Growth (YoY)	77.59%	53.34%	6.76%	21.43%	0.47%	10.15%
Cost of Revenue	718.84	548.17	263.73	239.22	217.46	179.98
Gross Profit	1,180	1,020	759.12	718.88	571.58	605.39
Selling, General & Admin	769.7	643.41	432.12	408.15	354.76	354.76
Research & Development	160.2	124.01	73.02	97.35	84.52	60.07
Other Operating Expenses	164.98	119.74	26.04	41.43	20.87	18.57
Operating Expenses	1,095	887.16	531.17	546.93	460.15	433.4
Operating Income	84.74	133.14	227.95	171.95	111.43	171.99
Interest Expense / Income	-11.74	-20.13	-14.23	-9.3	-13.95	-17.41
Other Expense / Income	2.83	-12.12	-0.84	0.84	-0.51	-0.55
Pretax Income	93.65	165.39	243.02	180.41	125.9	189.95
Income Tax	27.02	42.52	52.85	31.22	23.61	34.74
Net Income	66.63	122.87	190.17	149.19	102.29	155.21
Net Income Growth	-66.89%	-35.39%	27.47%	45.86%	-34.10%	-0.81%
Shares Outstanding (Basic)	135	113	100	101	99	99
Shares Outstanding (Diluted)	135	115	103	104	101	102
Shares Change	32.45%	11.68%	-0.95%	2.63%	-1.01%	0.67%
EPS (Basic)	0.59	1.09	1.89	1.48	1.04	1.57
EPS (Diluted)	0.62	1.07	1.85	1.44	1.01	1.52
EPS Growth	-68.53%	-42.16%	28.47%	42.57%	-33.55%	-1.30%
Free Cash Flow	151.72	165.23	104.42	219.38	135.14	101.23
Free Cash Flow Per Share	1.12	1.46	1.04	2.18	1.37	1.02
Gross Margin	62.14%	65.05%	74.22%	75.03%	72.44%	77.08%
Operating Margin	4.46%	8.49%	22.29%	17.95%	14.12%	21.90%
Profit Margin	3.51%	7.83%	18.59%	15.57%	12.96%	19.76%
Free Cash Flow Margin	7.99%	10.53%	10.21%	22.90%	17.13%	12.89%
Effective Tax Rate	28.85%	25.71%	21.75%	17.30%	18.76%	18.29%
EBITDA	263.79	290	297.04	240.98	174.82	225.27
EBITDA Margin	13.90%	18.49%	29.04%	25.15%	22.16%	28.68%
Depreciation & Amortization	181.89	144.73	68.25	69.87	62.87	52.73
EBIT	81.91	145.26	228.79	171.11	111.95	172.54
EBIT Margin	4.31%	9.26%	22.37%	17.86%	14.19%	21.97%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).